ES2083437T3 - Composiciones anti-inflamatorias para uso externo. - Google Patents

Composiciones anti-inflamatorias para uso externo.

Info

Publication number
ES2083437T3
ES2083437T3 ES90312313T ES90312313T ES2083437T3 ES 2083437 T3 ES2083437 T3 ES 2083437T3 ES 90312313 T ES90312313 T ES 90312313T ES 90312313 T ES90312313 T ES 90312313T ES 2083437 T3 ES2083437 T3 ES 2083437T3
Authority
ES
Spain
Prior art keywords
external use
inflammatory compositions
alkyl
ability
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90312313T
Other languages
English (en)
Inventor
Francisco Jose Evarist Stefano
Jorge Adrian Nowogrodski
Dar O Norberto Ramon Carrara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beta Pharmaceuticals Co
Original Assignee
Beta Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Pharmaceuticals Co filed Critical Beta Pharmaceuticals Co
Application granted granted Critical
Publication of ES2083437T3 publication Critical patent/ES2083437T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA PARA USO EXTERNO Y SU PREPARACION, DONDE UN COMPUESTO ESPECIFICO, CONOCIDO, ANTI-INFLAMATORIO NO-ESTEROIDE SE MEZCLA HOMOGENEAMENTE CON UN VEHICULO FARMACEUTICAMENTE ACEPTABLE, QUE INCLUYE AL MENOS UN COMPONENTE QUE TIENE LA PROPIEDAD DE INCREMENTAR LA PERMEABILIDAD PERCUTANEA Y QUE ES SELECCIONADO DE ACIDOS (C4-C30) GRASO Y SUS ESTERES ALQUILO Y ALCALENO.
ES90312313T 1989-11-14 1990-11-12 Composiciones anti-inflamatorias para uso externo. Expired - Lifetime ES2083437T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AR31543389 1989-11-14

Publications (1)

Publication Number Publication Date
ES2083437T3 true ES2083437T3 (es) 1996-04-16

Family

ID=3478737

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90312313T Expired - Lifetime ES2083437T3 (es) 1989-11-14 1990-11-12 Composiciones anti-inflamatorias para uso externo.

Country Status (7)

Country Link
EP (1) EP0428352B1 (es)
JP (1) JPH03275621A (es)
AT (1) ATE126054T1 (es)
BR (1) BR9005878A (es)
DE (1) DE69021511T2 (es)
DK (1) DK0428352T3 (es)
ES (1) ES2083437T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
HU209518B (en) * 1992-12-23 1994-06-28 Egyt Gyogyszervegyeszeti Gyar Process for production of free of skin damaging effect unguent preparation containing piroxicam
JP4181232B2 (ja) 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
WO1999039713A1 (en) * 1998-02-09 1999-08-12 Chong Kun Dang Pharmaceutical Corp. Piroxicam-containing hydroalcoholic gel composition
WO1999055660A1 (en) * 1998-04-28 1999-11-04 Russinsky Limited Process for the preparation of aceclofenac
JP2000143540A (ja) * 1998-11-06 2000-05-23 Bristol Myers Squibb Co 非ステロイド系消炎鎮痛薬含有外用剤
DE102007034976A1 (de) 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren
CA3082286A1 (en) 2017-12-04 2019-06-13 Johnson & Johnson Consumer Inc. Topical emulsion composition containing nonsteroidal anti-inflammatory drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837025A (en) * 1988-03-25 1989-06-06 Laboratoires D'hygiene Et De Dietetique Self-adhesive device for the percutaneous administration of an active ingredient

Also Published As

Publication number Publication date
EP0428352B1 (en) 1995-08-09
BR9005878A (pt) 1991-09-24
DE69021511D1 (de) 1995-09-14
ATE126054T1 (de) 1995-08-15
EP0428352A1 (en) 1991-05-22
DK0428352T3 (da) 1995-12-27
DE69021511T2 (de) 1996-11-21
JPH03275621A (ja) 1991-12-06

Similar Documents

Publication Publication Date Title
ATE53301T1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
DK44389A (da) Synergisk antioxidantblanding
DE3866645D1 (de) Dispergierzusatzgemisch fuer oelzusammensetzungen.
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
NL930034I1 (nl) Toepassing van 1,4-dihydro-2,6-dimethyl-4-(3-nitrofenyl)pyridine-3-beta-methoxy-ethylester-5-isopropylester ter bereiding van cerebraal werkzame geneesmiddelen
FI931031A (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
ES2193217T3 (es) Combinacion de un bencimidazol que tiene actividad antagonista de aangiotensina ii con un diuretico.
EP0266992A3 (en) Prevention of glucocorticoid-induced skin atrophy
PT82646B (pt) Processo para a preparacao de composicoes farmaceuticas liofilizadas contendo um activador de plasminogeneo de tecidos
BR8900004A (pt) Composicoes herbicidas de compostos de heterociclicos-alcoilenos de quinoxaliniloxifenoxipropanoato
ES2083437T3 (es) Composiciones anti-inflamatorias para uso externo.
ES2062375T3 (es) Composiciones farmaceuticas que contienen un complejo de zinc.
EE9400257A (et) Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks
IT8748469A0 (it) Composizioni farmaceutiche a cessione ritardata
NO891647D0 (no) Fremgangsmaate for desodorisering av fettsyreesterblandinger.
DK99987A (da) Oestrogenpraeparater
BR9203501A (pt) Ester de acido 1-alcoxihexatrien-2-carboxilico,composicao praguicida,processos para o combate de pragas,para a preparacao de esteres e para a preparacao de composicoes e uso
AR240400A1 (es) Procedimiento para obtener nuevas composiciones sinergicas para uso veterinario.
SE7507413L (sv) Galenisk beredning.
BR8706462A (pt) Composicao de ester de polieterimida
IT8721981A0 (it) Composizione farmaceutica antiinfiammatoria ad effetto prolungato ad uso topico
PT87031A (pt) Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
BR7804295A (pt) Processo para a preparacao de esteres de acidos n,n-dialquil-o-pirimidinil-carbamicos,composicoes inseticidas e emprego
ATE3282T1 (de) Alpha-difluormethyl-alpha-aminosaeuren und sie enthaltende pharmazeutische zusammensetzung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 428352

Country of ref document: ES